Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Crit Care Med. 2013 Nov;41(11):10.1097/CCM.0b013e318298291a. doi: 10.1097/CCM.0b013e318298291a

Table 2.

Primary outcomes.

Outcome Electronic checklist (N=125) Prompted (N=171) P Value
Patient-days on which empirical antibiotics were used, no. (%) 498/711 (70.0) 702/1112 (63.1) 0.002
Proportion of antibiotic-days on which empirical antibiotics were used, mean (SD)a 0.83 (0.27) 0.78 (0.27) 0.093
Empirical antibiotic duration (d), median [IQR] 3 [2–4] 3 [1–5] 0.27
Total antibiotic duration (d), median [IQR] 4 [2–8] 4 [2–7] 0.65
a

Empiric antibiotic-days/total antibiotic-days.

HHS Vulnerability Disclosure